Literature DB >> 2010641

Bioactive and inactive forms of tumor necrosis factor-alpha in spinal fluid from patients with meningitis.

B Møller1, S C Mogensen, P Wendelboe, K Bendtzen, C M Petersen.   

Abstract

Twenty-four patients, including 12 with meningitis, were admitted with meningeal symptoms and fever. Their serum and spinal fluid tumor necrosis factor-alpha (TNF alpha) levels were determined by ELISA. TNF alpha immunoreactivity was found in spinal fluid of 10 meningitis patients and one nonmeningitis patient, whereas 7 sera, 5 from meningitis patients, contained TNF alpha. Levels were significantly higher in spinal fluids than in serum samples, and the TNF alpha bioactivity of spinal fluids and sera was considerably below predictions based on ELISA measurements. Gel filtration chromatography demonstrated the presence of both polymeric (greater than 200 kDa) and oligomeric (10-40 kDa) TNF alpha in spinal fluid. Significant bioactivity was obtained only from samples containing oligomeric cytokine. In agreement with previous in vitro findings, these results strongly indicate that bioactive TNF alpha oligomers form inactive polymers and monomers, which could contribute to the observed in vivo discrepancies between immunoreactive and bioactive protein. Finally, the data support the concept of local central nervous system production of TNF alpha in meningitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010641     DOI: 10.1093/infdis/163.4.886

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels.

Authors:  A Corti; G Fassina; F Marcucci; E Barbanti; G Cassani
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

3.  Development of an in vitro Bioassay for Recombinant Human Erythropoietin (rHuEPO) Based on Proliferative Stimulation of an Erythroid Cell Line and Analysis of Sialic Acid Dependent Microheterogeneity: UT-7 Cell Bioassay.

Authors:  Manoj Kumar Metta; Vasavi Malkhed; Srinivasan Tantravahi; Uma Vuruputuri; Rajkumar Kunaparaju
Journal:  Protein J       Date:  2017-04       Impact factor: 2.371

4.  Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.

Authors:  Andrea Zelmer; Melissa J Martin; Ozan Gundogdu; George Birchenough; Rebecca Lever; Brendan W Wren; J Paul Luzio; Peter W Taylor
Journal:  Microbiology (Reading)       Date:  2010-04-15       Impact factor: 2.777

Review 5.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

6.  Differential gene expression during meningeal-meningococcal interaction: evidence for self-defense and early release of cytokines and chemokines.

Authors:  D B Wells; P J Tighe; K G Wooldridge; K Robinson; D A Ala' Aldeen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection.

Authors:  J S Friedland; Y Suputtamongkol; D G Remick; W Chaowagul; R M Strieter; S L Kunkel; N J White; G E Griffin
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis.

Authors:  S Ohga; T Aoki; K Okada; H Akeda; K Fujioka; A Ohshima; T Mori; I Minamishima; K Ueda
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

Review 9.  Bacterial meningitis: mechanisms of disease and therapy.

Authors:  R F Kornelisse; R de Groot; H J Neijens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

10.  Intrathecal IgM response in disseminated cerebrospinal metastasis from malignant melanoma.

Authors:  M Weller; A Stevens; N Sommer; H Wiethölter
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.